SALFARM DANMARK A/S: Financial statements 2012
CVR: 67456211
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
SALFARM DANMARK A/S (CVR 67456211) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 8,640,655 and a net result of DKK 3,830,419. Equity in the 2012 report amounted to DKK 7,504,738. The solvency ratio was 57.6%.
- Gross Profit
- DKK 8,640,655
- Profit/Loss
- DKK 3,830,419
- Equity
- DKK 7,504,738
- Total Assets
- DKK 13,036,107
Official annual report
Keep an eye on SALFARM DANMARK A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of March 23, 2012, Bodil Olsen has joined the board of directors of SALFARM DANMARK A/S.
As of March 23, 2012, Karen Nørgaard Olsen has left the board of directors of SALFARM DANMARK A/S.
About SALFARM DANMARK A/S
SALFARM DANMARK A/S is a Danish company of the type Aktieselskab based in Kolding, founded in 1981. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Peter Wendorff Olsen. The board consists of Michael Degn-Mortensen (chair), Peter Wendorff Olsen and Simon Damkjær Wille. The company is owned by SALPHARM HOLDING ApS. The company has 31 employees (2026). In 2025, the company reported a gross profit of DKK 68,137,143 and a net result of DKK 37,103,807 compared with DKK 31,245,958 the year before. Equity in the 2025 report amounted to DKK 41,267,696.